Rheumatology

A concerning increase in the incidence of central nervous system (CNS) demyelination among patients undergoing biologic treatments for rheumatologic diseases has been revealed by a new study.

Maintaining an INR between 2.5 and 3.5 may significantly reduce the risk of recurrent thrombotic events in patients with primary antiphospholipid syndrome (APS), particularly arterial events, according to a new retrospective study.

A new multicomponent vaccine targeting both seasonal influenza and SARS-CoV-2 has demonstrated noninferior immunogenicity and acceptable safety in adults aged 50 years and older, according to results from a Phase III randomized trial.

Menopause status significantly shapes the clinical presentation of systemic sclerosis (SSc), according to new findings from a multicenter analysis of over 1,500 women enrolled in the SPRING-SIR registry.

A new comparative analysis of international guidelines for psoriatic arthritis (PsA) management reveals key divergences in treatment strategies across leading rheumatology societies, underscoring ongoing challenges in global consensus despite shared therapeutic goals.

In a new multicenter study, researchers found that the effectiveness of a computerized patient decision aid (PtDA) for systemic lupus erythematosus (SLE) hinges not on where or how it is used but on whether patients view it fully and without interruptions.

Muscle impairments are a significant yet understudied burden in patients with osteogenesis imperfecta (OI), with consequences that extend far beyond bone fragility.

Lupus nephritis recurrence after kidney transplant may occur silently and more frequently than previously recognized, according to a new multisite retrospective study using both surveillance and indication biopsies.